ID   EFNA1_RAT               Reviewed;         205 AA.
AC   P97553; Q6NS29;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 2.
DT   29-MAY-2024, entry version 152.
DE   RecName: Full=Ephrin-A1;
DE   AltName: Full=EPH-related receptor tyrosine kinase ligand 1;
DE            Short=LERK-1;
DE   AltName: Full=Immediate early response protein B61;
DE   Contains:
DE     RecName: Full=Ephrin-A1, secreted form;
DE   Flags: Precursor;
GN   Name=Efna1; Synonyms=Epgl1, Lerk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=7675446;
RA   Takahashi H., Ikeda T.;
RT   "Molecular cloning and expression of rat and mouse B61 gene: implications
RT   on organogenesis.";
RL   Oncogene 11:879-883(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Cell surface GPI-bound ligand for Eph receptors, a family of
CC       receptor tyrosine kinases which are crucial for migration, repulsion
CC       and adhesion during neuronal, vascular and epithelial development.
CC       Binds promiscuously Eph receptors residing on adjacent cells, leading
CC       to contact-dependent bidirectional signaling into neighboring cells.
CC       Plays an important role in angiogenesis and tumor neovascularization.
CC       The recruitment of VAV2, VAV3 and PI3-kinase p85 subunit by
CC       phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase
CC       activation and vascular endothelial cell migration and assembly. Exerts
CC       anti-oncogenic effects in tumor cells through activation and down-
CC       regulation of EPHA2. Activates EPHA2 by inducing tyrosine
CC       phosphorylation which leads to its internalization and degradation.
CC       Acts as a negative regulator in the tumorigenesis of gliomas by down-
CC       regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal
CC       growth cone and regulates dendritic spine morphogenesis (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Homodimer. Forms heterodimers with EPHA2. Binds to
CC       the receptor tyrosine kinases EPHA2, EPHA3, EPHA4, EPHA5, EPHA6 and
CC       EPHA7. Also binds with low affinity to EPHA1 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P20827};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P20827}.
CC   -!- SUBCELLULAR LOCATION: [Ephrin-A1, secreted form]: Secreted
CC       {ECO:0000250|UniProtKB:P20827}.
CC   -!- PTM: Undergoes proteolysis by a metalloprotease to give rise to a
CC       soluble monomeric form. {ECO:0000250}.
CC   -!- PTM: N-Glycosylation is required for binding to EPHA2 receptor and
CC       inducing its internalization. {ECO:0000250|UniProtKB:P20827}.
CC   -!- SIMILARITY: Belongs to the ephrin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00884}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38056; BAA07242.1; -; mRNA.
DR   EMBL; BC070514; AAH70514.1; -; mRNA.
DR   RefSeq; NP_446051.2; NM_053599.2.
DR   AlphaFoldDB; P97553; -.
DR   SMR; P97553; -.
DR   STRING; 10116.ENSRNOP00000027920; -.
DR   GlyCosmos; P97553; 1 site, No reported glycans.
DR   GlyGen; P97553; 1 site.
DR   PhosphoSitePlus; P97553; -.
DR   PaxDb; 10116-ENSRNOP00000027920; -.
DR   GeneID; 94268; -.
DR   KEGG; rno:94268; -.
DR   UCSC; RGD:620388; rat.
DR   AGR; RGD:620388; -.
DR   CTD; 1942; -.
DR   RGD; 620388; Efna1.
DR   VEuPathDB; HostDB:ENSRNOG00000020573; -.
DR   eggNOG; KOG3858; Eukaryota.
DR   HOGENOM; CLU_081598_2_0_1; -.
DR   InParanoid; P97553; -.
DR   OrthoDB; 2881104at2759; -.
DR   PhylomeDB; P97553; -.
DR   Reactome; R-RNO-2682334; EPH-Ephrin signaling.
DR   Reactome; R-RNO-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-RNO-3928665; EPH-ephrin mediated repulsion of cells.
DR   PRO; PR:P97553; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000020573; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0046875; F:ephrin receptor binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; NAS:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0003199; P:endocardial cushion to mesenchymal transition involved in heart valve formation; ISO:RGD.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0003183; P:mitral valve morphogenesis; ISO:RGD.
DR   GO; GO:0061002; P:negative regulation of dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:1903051; P:negative regulation of proteolysis involved in protein catabolic process; ISO:RGD.
DR   GO; GO:0070244; P:negative regulation of thymocyte apoptotic process; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0014028; P:notochord formation; ISO:RGD.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0045765; P:regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISO:RGD.
DR   GO; GO:0043535; P:regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0033628; P:regulation of cell adhesion mediated by integrin; ISO:RGD.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:RGD.
DR   CDD; cd10425; Ephrin-A_Ectodomain; 1.
DR   Gene3D; 2.60.40.420; Cupredoxins - blue copper proteins; 1.
DR   InterPro; IPR008972; Cupredoxin.
DR   InterPro; IPR031328; Ephrin.
DR   InterPro; IPR034252; Ephrin-A_Ecto.
DR   InterPro; IPR019765; Ephrin_CS.
DR   InterPro; IPR001799; Ephrin_RBD.
DR   PANTHER; PTHR11304; EPHRIN; 1.
DR   PANTHER; PTHR11304:SF19; EPHRIN-A1; 1.
DR   Pfam; PF00812; Ephrin; 1.
DR   PRINTS; PR01347; EPHRIN.
DR   SUPFAM; SSF49503; Cupredoxins; 1.
DR   PROSITE; PS01299; EPHRIN_RBD_1; 1.
DR   PROSITE; PS51551; EPHRIN_RBD_2; 1.
PE   2: Evidence at transcript level;
KW   Angiogenesis; Cell membrane; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Lipoprotein; Membrane; Reference proteome; Secreted; Signal;
KW   Tumor suppressor.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..182
FT                   /note="Ephrin-A1"
FT                   /id="PRO_0000008357"
FT   CHAIN           18..?
FT                   /note="Ephrin-A1, secreted form"
FT                   /id="PRO_0000389633"
FT   PROPEP          183..205
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000008358"
FT   DOMAIN          18..151
FT                   /note="Ephrin RBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00884"
FT   LIPID           182
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        26
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        51..92
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00884"
FT   DISULFID        80..140
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00884"
FT   CONFLICT        18
FT                   /note="A -> V (in Ref. 1; BAA07242)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        68
FT                   /note="T -> S (in Ref. 1; BAA07242)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        90
FT                   /note="W -> V (in Ref. 1; BAA07242)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        159
FT                   /note="A -> V (in Ref. 1; BAA07242)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   205 AA;  23763 MW;  E9ED3F73AE7FC4CA CRC64;
     MEFLWAPLLG LCCSLAAADR HIVFWNSSNP KFREEDYTVH VQLNDYLDII CPHYEDDSVA
     DAAMERYTLY MVEHQEYVTC EPQSKDQVRW KCNQPSAKHG PEKLSEKFQR FTPFTLGKEF
     KEGHSYYYIS KPIYHQETQC LKLKVTVNGK ITHSPHAHAN PQEKRLQADD PEVQVLHSIG
     HSAAPRLFPL VWAVLLLPLL LLQTQ
//
